Browse
related articles
Novartis supports development of regional health sector
- United Arab Emirates: Saturday, February 14 - 2004 at 10:52
- PRESS RELEASE
Novartis, a world leader in pharmaceuticals and consumer health, today announced that the development of local talent and partnerships would form the core of its growth strategy in the region in 2004.
"Partnership and the development of local talent have made a strong contribution to our growth and development as a company, and ensure that we make a positive impact upon the communities where we operate," said Stewart Fairbairn, general manager, Novartis.
The announcement came shortly after Novartis hosted a major meeting of over 320 Middle East and African associates at a meeting in Dubai, where the company laid out a roadmap for development in the region over the coming year.
The healthcare leader, which occupies a number one or number two position in each of the Middle East's major healthcare markets, has built its presence in the region through an innovation-focused strategy and strong relationships with local partners, some of which date back as far as the 1960s.
Fairbairn praised the work of The Mohammed bin Rashid Program for Leadership Development in the UAE, which focuses on mentoring nationals for leadership roles in industry.
One of the company's stated goals for 2004 is to extend support for programs that develop national talent across the Middle East.
"Working in cooperation with programs like the Mohammed bin Rashid Program contributes to our success because it ensures that Novartis works with the best people in a deep pool of potential talent in the region. For the Middle East to thrive as a healthcare hub, it needs to nurture and develop the next generation of potential leaders, and we're delighted to support initiatives that contribute to this process," concluded Fairbairn.
Also consider reading:
Browse
related articles
Notes and media contacts
About NovartisNovartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2002, the Group's businesses achieved sales of USD 20.9 billion and a net income of USD 4.7 billion. The Group invested approximately USD 2.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 78,200 people and operate in over 140 countries.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Posted by Christine H. Andersen, Assistant News Editor
